ArticleFrontiers in immunology2025

Emerging causes of anticancer therapies-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: evidence from disproportionality analysis of the FDA adverse event reporting system.

Wensheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.